1 hour ago
Eli Lilly (LLY) Stock Faces HSBC Downgrade Amid Obesity Market Concerns
Eli Lilly (LLY) stock declined after HSBC downgrade to Reduce with $850 price target, citing obesity drug market risks and pricing pressures.
The post Eli Lilly (LLY) Stock Faces HSBC Downgrade Amid Obesity Market Concerns appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
Robinhood (HOOD) RVI Fund Completes $34.5M Investment in Stripe and ElevenLabs
- 1 hour ago
Why Defense Stocks Aren’t Rallying Despite Billions Spent on Iran Conflict
- 1 hour ago
Qualcomm (QCOM) Stock Jumps 3% on Massive $20B Share Repurchase Plan
- 1 hour ago
OpenAI Partners with AWS to Distribute AI Solutions to Federal Government Agenci...
- 1 hour ago
Nebius (NBIS) Stock Volatility: $27B Meta Deal, $3.75B Bond Raise, and CrowdStri...
